DRUGS MADE IN AMER ACQUTN CO

Historical 13F Holders

Symbol
DMAA
CUSIP
G2847J104
All holders as of
Q3 2026
Type
Equity
Class
ORD SHS
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for G2847J104 since 12/18/2024, largest first.

Filer % of Class Filed
Drugs Made In America Acquisition LLC 13D
12.5% 3/3/2025
Event 2/18/2025
Karpus Management, Inc. 13G/A 10.3% 8/14/2026
Event 6/30/2026
Mizuho Financial Group, Inc. 13G/A 8.5% 8/13/2026
Event 6/30/2026
Polar Asset Management Partners Inc. 13G 5.7% 5/15/2025
Event 3/31/2025
Feis Equities LLC 13G
5.1% 6/26/2026
Event 6/18/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
Hudson Bay Capital Management LP 13G/A
4.6% 11/12/2025
Event 9/30/2025
Glazer Capital, LLC 13G/A
4.1% 8/13/2026
Event 6/30/2026
First Trust Capital Management L.P. 13G/A
3.2% 8/14/2026
Event 6/30/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 23 14.4 M $147M
2026 Q2 23 14.0 M $146M
2026 Q1 39 22.9 M $237M
2025 Q4 39 22.6 M $232M
2025 Q3 37 21.8 M $223M
2025 Q2 33 20.8 M $212M
2025 Q1 25 19.7 M $171M